Publication of the positive phase 2/3 clinical trial with masitinib in ALS in the journal ALSFD
08/07/2019 – AB Science announces the publication of the positive phase 2/3 clinical trial with masitinib in ALS in the journal Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.